CK19-2G2 may be a candidate marker for diagnosing and monitoring a patient's response to lung cancer treatment. In addition, CK19-2G2 may be an indicator for micrometastases in lung cancer patients.
8
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text
Non-Small Cell Lung Cancer Guidelines
David S. Ettinger, Gerold Bepler, Raphael Bueno et al. · Journal of the National Comprehensive Cancer Network · 2006 · 138 citations · Full text